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An extract of human seminal plasma was found to have inhibin-like activity. The active factor was purified 
to homogeneity by ion exchange chromato~aphy, molecular sieving and high performance liquid 
chromatography. The purified material has a mass of approximately 5 kDa and is very basic. Amino acid 
analysis howed the presence of approximately 35 residues while the sequencing data allowed the 
determination f the N-terminal 31 amino acids. There is a possibility of an additional 2-4 residues at the 
C-terminus, which could not be determined. 
rnhibin Sequence Fragment 
1. INTRODUCTION 2. MATERIALS AND METHODS 
‘fnhibin’ was first described in 1932 [l] and was 
thought to have an important effect on the secre- 
tion of pituitary follicle-stimulating hormone 
(FSH) [2]. More recently, evidence coming from 
different laboratories revealed that inhibin is a 
polypeptide or proteinaceous molecule present in 
extracts of numerous gonadal-related fluids of dif- 
ferent species [3-81. Different types of isolation 
procedures have been described, but complete 
purification and chemical characterization of the 
active principle is yet to be achieved. 
2.1. rs~iati~~ and purification of Dugan 
inhibin-like peptide 
The ethanolic precipitate obtained from human 
In human seminal plasma, different active frac- 
tions were obtained and found to have molecular 
masses varying from 5 to >lOO kDa [9]. This 
*heterogeneity in addition to the basic nature of the 
low A4, component delayed much of their 
characterization. The 5 kDa material was finally 
isolated [9, IO] to homogeneity and its biological as 
well as chemical properties were determined. Here, 
we report its chemical characterization. 
ejaculates (sperm-free) was put through a series of 
isolation steps including ion-exchange chromato- 
graphy on sulphopropyl-Sephadex C-50, DEAE 
Sephadex A-25, gel filtration on Sephadex G-50, 
and finally successive HPLC using Cl 8 micro Bon- 
dapak column. Details of the purification pro- 
cedure and biological activities have been describ- 
ed [9,10]. Purity of the material was assessed by 
different methods including polyacrylamide gel 
electrophoresis at pH 4.5 which also confirmed its 
basic nature as suggested by its behavior during 
ion-exchange chromatography. Gel filtration on 
Sephadex-50 suggested an apparent molecular 
mass of 4-5 kDa. 
2.2. Amino acid analysis and sequencing 
procedure 
+ To whom correspondence shouId be addressed 
Seminal pt~~a Composition 
Amino acid analysis was done following acid 
hydrolysis (6 N HCl at 110°C for 22 h) on a 
Beckman model 121M analyzer. Amino acid se- 
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quence was performed on a Beckman 890C 
automatic sequenator using a 0.3 M Quadrol pro- 
gram [11,12] and 3 mg of Polybrene (Aldrich) as a 
carrier. The instrument is equipped with a Se- 
quemat P-6 autoconverter for PTH conversion 
(using methanolic HCl) and a model SC-510 con- 
troller for automatic program switching. The 
phenylthiohydantoin residues were analyzed by 
HPLC using an Altex 5~-ODS column and a 
Varian LC-5060/Vista 401 apparatus as previously 
described [ 11,121. The integrated yield of each 
PTH-amino acid was then plotted as a function of 
cycle number as shown in fig. 1. 
2.3. Computer data bank search 
The possible homologies of the deduced se- 
quence was verified using a computer mutation 
data matrix procedure as developed by the late Dr 
M.O. Dayhoff of the National Biomedical 
Research Foundation, Georgetown University in 
Washington, DC. 
3. RESULTS 
The amino acid analysis (table 1) of the isolated 
human seminal plasma peptide revealed that it is a 
Table 1 
Amino acid composition of inhibin-like peptide 
Amino 
acid 
Mean f SE 
(n = 6) 
Nearest 
integer 
Available 
structure 
data 
Lys 5.47 f 0.29 5 5 
His 6.6 * 0.5 7 7 
Arg 2.8 f 0.06 3 3 
-4s~ 3.8 f 0.2 4 3 
Ser 1.54 * 0.09 l-2 1 
GlU 2.5 + 0.08 2-3 2 
GlY 5.8 + 0.4 6 5 
Ala 0.96 * 0.07 1 1 
Val 2.0 + 0.05 2 2 
Ile” 1.0 1 I 
Phe 0.9 + 0.1 1 1 
a Ile was taken as the reference amino acid, from which 
the composition was calculated 
Samples were hydrolyzed in 6 N HCl at 110°C for 22 h. 
Thr, Met, Cys, Pro, Leu, Tyr are absent. Trp was not 
analyzed. Hexosamines were not detectable 
highly basic peptide containing up to 35 amino 
acids. It is important to note the absence of Thr, 
Met, Cys, Pro, Leu and Tyr. The exact number of 
residues will be discussed later. 
The strategy employed for the sequence involved 
3 consecutive sequence runs. In the first one 
300 pmol of the peptide was deposited on the se- 
quenator cup and double coupling performed for 
the first cycle only. This was then followed by the 
normal single coupling procedure. This 
methodology allowed the unambiguous determina- 
tion of the first 20 amino acids. It was then decided 
to repeat the sequence with 3 nmol of the peptide 
using an identical strategy. In a second sequence 
run, due to the availability of more material at the 
start, it was possible to extend the sequence to 31 
cycles. Although low amounts of amino acids were 
detected past residue 31, it was not possible to 
unambiguously identify them. Furthermore, at this 
level of starting material it became clear that the 
peptide preparation was contaminated by 
fragments of the 31 amino acid sequence deter- 
mined (fig.3). These included peptides starting at 
residues 19, 2 and 10 of the original major se- 
quenceable material. If we denote the 31 amino 
acid sequence as the N sequence (see fig.3), then 
the latter are then denoted N-18, N-l and N-9, 
respectively. In order to confirm the sequence ob- 
tained, to possibly extend it at the carboxy- 
terminal and to quantitate the amounts of con- 
taminating fragments it was then decided to repeat 
the sequence with the ‘same strategy but the 
analysis of the residues was performed as soon as 
the PTH amino acid came out of the sequenator. 
In this case, about 30 nmol of peptide was used at 
the start. 
In fig.1 are represented the yields of each PTH 
amino acid as a function of sequenator cycle 
number. First, it is clear that within the 31 amino 
acid sequence, Thr, Met, Cys, Pro, Leu, Tyr and 
Trp are absent, thus confirming similar results ob- 
tained with the amino acid analysis. Second, it is 
evident that the N sequence represents the major 
one and that the N-18, N-l and N-9 fragments 
represent about 20, 18 and 18%) respectively, of 
the N peptide, as calculated from the regression 
lines shown in fig.2. Therefore, in order to dissect 
the data and calculate the yields for each one of 
these polypeptide chains, in fig.2 are shown the 
linear regression lines for the N, N-18 and N-l se- 
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Fig.1. Yield of the various amino acids obtained during the sequence of the human inhibin-like peptide isolated. 
Following residue 3 1, no more assignment of amino acids was possible due to very low yields. The numbers above each 
peak represent he deduced position occupied by that amino acid along the peptide chain. Although other peaks are 
apparent, e.g., Ala at position 10, Ile at position 3, Phe at position 7, Ser at position 3, these are deduced to have come 
from the N-18 and N-9 fragments, respectively (see section 3). The contribution of the N-l segment is apparent by the 
presence of a preview peak before each amino acid assigned for the N chain. Numbers in parentheses (in Asp and Glu 
graphics) represent he yields of either Asp or Glu originating from partial hydrolysis of the parent Asn or Gln, 
respectively, assigned at these positions. 
quences. The regression line for the N-9 sequence 
could not be calculated with accuracy in view of 
overlapping amino acids. However, the N-9 se- 
quence is clearly present upon analysis of the data 
for Ser and Phe at positions 3 and 7 of the se- 
quence, respectively, as shown in fig.2, which 
would correspond to Ser 12 and Phe 16 in the N se- 
quence (see fig.3). This strategy, therefore, 
allowed the determination with certainty of the se- 
quence of the first 31 amino acids of the human 
seminal plasma peptide isolated. The sequence of 
the N-18, N-l and N-9 peptides allows further con- 
firmation of the validity of the assignment of the 
amino acids within the N sequence. Interestingly, 
when one carefully analyzes the data from fig.1 
and 2, it becomes evident that the various chains 
simultaneously analyzed were sequenced with dif- 
ferent degrees of ease. For example, although the 
N sequence has an initial yield of 24.4 nmol yet the 
repetitive yield for this chain is only 89.5%. The 
N-l chain shows an initial yield of 4.4 nmol and a 
repetitive yield of 92.1%. As for the shorter N- 18 
chain, it is clear that the yield dropped sharply 
following the Gly-Gly sequence (residues 25-26 of 
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the N sequence). Therefore, although the initial 
and repetitive yields are, respectively, 4.8 nmol 
and 98.5%, yet following the Gly-Gly sequence, 
the repetitive yield drops to 65.9%. 
Accordingly, the proposed amino terminal se- 
quence of the human seminal plasma peptide 
isolated and exhibiting inhibin-like activity [9, lo] 
is depicted in fig.3. 
- 
Fig.2. Calculated PTH yields of each amino acid 
assigned to a particular chain of the inhibin-like peptide, 
plotted on a semi-logarithmic scale as a function of 
sequenator cycle number. (A) Here the yields of each 
amino acid obtained for the major N sequence (see fig.3) 
are depicted together with the best line fit obtained by 
linear regression analysis. Each amino acid assigned at a 
given position is depicted in a one letter code. Based on 
the best line fit we calculate the initial yield at cycle 1 to 
be 24.4 nmol and the average decline in sequence yield, 
termed repetitive yield (obtained from the slope of the 
line) to be 89.5%. Some residues such as Ser are very 
labile, and accordingly are obtained in low yield, e.g., 
Ser 12. (B) Same calculations were done as for (A) for 
the less abundant N-18 chain. The initial yield obtained 
from the intercept of the best line fit with the ordinate 
is found to be 4.8 nmol and the repetitive yield of the 
first 9 cycles to be 98.5%. Following cycle 9, a sharp 
drop in yield is observed giving a repetitive yield for this 
part of the sequence as 65.9%. (C) A similar calculation 
for the N-l peptide chain sequence predicts an initial 
yield for this peptide of 4.4 nmol and an average 
repetitive yield of 92.1%. However, for this chain no 
further sequence assignment was possible following 
residue 28 which could indicate that a cleavage at His 29 
(of the N chain numbering) could have occurred giving 
rise to a 28 residues chain in the original peptide 
preparation. Alternatively, the sequence might have 
terminated precociously at that particular cycle. From 
the data shown in fig.1 it can be calculated, based on 
Phe 7 and Ser 3 that the initial yield of the N-9 chain is 
very similar to the N-l chain:However, due to similarity 
of residues from different chains at each cycle, we 
cannot calculate with certainty the repetitive yield of the 
sequence of this N-9 fragment. From the initial yield 
data it can, therefore, be calculated that the original 
peptide preparation contained at least a mixture of 4 
peptides representing the N, N-18, N-l and N-9 segments 
of the proposed sequence at a ratio of 1: 0.20: 0.18 : 0.18, 
respectively. 
Fig.3. Proposed amino terminal sequence of the isolated 
human peptide exhibiting inhibin-like activity. The 
arrows represent he deduced cleavage sites, within the 
original peptide preparation, possibly responsible for the 
generation of the observed N-l (HislArg cleavage), N-9 
(His&Asp cleavage) and N-18 (Arg 1Val cleavage) 
fragments. 
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4. DISCUSSION 
From the determined amino acid composition 
(see table l), it can be inferred that no more than 
2-4 additional amino acids could possibly be pre- 
sent at the carboxy-terminus of this peptide. In 
fig.3 are shown the inferred cleavage positions 
along the peptide chain which would be responsi- 
ble for the generation of the N-l, N-9 and N-18 
fragments observed. Interestingly, these imply a 
cleavage at the carboxy-terminus of either His (for 
N-l and N-9) or Arg (for N-l 8). It is not clear at 
present what the significance of such cleavage is or 
whether this is generated artefactually during the 
isolation and purification procedures employed. 
In order to ascertain the possible homology be- 
tween the determined sequence with that of any 
known protein or segment of protein, a computer 
sequence data bank search was initiated in col- 
laboration with the late Dr Margaret 0. Dayhoff. 
The results of such an exhaustive search revealed 
that this is a novel peptide. Furthermore, it was 
shown that out of 2145 protein sequences known 
representing a total of about 350000, 30 amino 
acid segments screened no more than 33% 
homology could be found with any known protein 
or segment of protein. However, such a search 
revealed that the best match was found to be with 
the segment 43-73 of either Baker’s yeast enolase 
(10 residues out of 31) or yeast enolase (9 residues 
out of 31) both sequences being translated from 
the nucleotide sequence of yeast enolases published 
in [13] and [14]. Since enolase, a dimer of identical 
chains, catalyzes the formation of phosphoenol- 
pyruvate in the glycolytic pathway, it is not clear at 
present if the observed homology has any signifi- 
cant meaning. Interestingly, antibodies to neuron 
specific enolase (NSE) and non-neuronal enolase 
(NNE) have been used as specific markers of 
neuronal and glial cells respectively [15]. These 
antibodies were also used to stain a number of 
amino precursor uptake and decarboxylation 
(APUD) cells [16] including those of endocrine 
cells. The homology of the isolated peptide with 
inhibin-like activity to enolase might be responsi- 
ble for some cross-reactivity with these antibodies, 
a possibility which has to be verified experimental- 
ly. A similar type of homology was found between 
a recently isolated novel hypothalamic-pituitary 
peptide with pro-insulin [ 17,181. Finally, data such 
as presented herein should stimulate further 
102 
studies in establishing the molecular relationships 
among inhibin-like factors present in gonadal 
fluids. 
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